Clinical Trials Directory

Trials / Conditions / Squamous Cell Carcinoma of the Skin

Squamous Cell Carcinoma of the Skin

26 registered clinical trials studyying Squamous Cell Carcinoma of the Skin — 4 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationThe Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.
NCT07347392
University of Aarhus—
Not Yet RecruitingDrug Screening of Cutaneous Lesions of Squamous Cell Carcinoma
NCT06782399
Oliver JonasEARLY_Phase 1
CompletedCivaDerm(TM) Surface Therapy Pilot Study
NCT04480645
CivaTech OncologyEARLY_Phase 1
Active Not RecruitingIntratumoral PH-762 for Cutaneous Carcinoma
NCT06014086
Phio Pharmaceuticals Inc.Phase 1
Active Not RecruitingEnhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopa
NCT06327971
Queen Mary University of London—
UnknownCarrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin
NCT05886140
Henan Cancer HospitalN/A
UnknownCamrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma
NCT05490485
Henan Cancer HospitalPhase 2
UnknownImmune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy
NCT05246228
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia—
CompletedDecisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region
NCT05482880
Maastricht University Medical Center—
RecruitingClinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiothe
NCT04892849
University of Erlangen-Nürnberg Medical School—
TerminatedThe UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy
NCT03737721
AHS Cancer Control AlbertaPhase 2
CompletedSL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
NCT03894618
Shattuck Labs, Inc.Phase 1
UnknownElucid Labs AIDA™ - Labelled Image Acquisition Protocol
NCT03621462
Elucid Labs Inc.N/A
TerminatedHow Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
NCT03370861
Washington University School of Medicine—
UnknownStudy of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC
NCT03291002
CureVacPhase 1
RecruitingNivolumab for Treatment of Squamous Cell Carcinoma of the Skin
NCT04204837
Salzburger LandesklinikenPhase 2
UnknownInvestigation of Desmoplastic Squamous Cell Carcinoma
NCT02717936
University Hospital TuebingenN/A
CompletedCetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer
NCT02324608
Rutgers, The State University of New JerseyN/A
CompletedPreventing Squamous Cell Skin Cancer
NCT02347813
University of RochesterPhase 2
TerminatedTreatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)
NCT01984892
Nina BhardwajPhase 2
TerminatedCapecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin
NCT01823679
Stanford UniversityPhase 2
WithdrawnIsolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma
NCT02507076
Albert Einstein College of MedicineN/A
WithdrawnPhase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma
NCT01465815
OHSU Knight Cancer InstitutePhase 1 / Phase 2
CompletedDasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chro
NCT00563290
National Cancer Institute (NCI)Phase 2
CompletedGefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Rec
NCT00126555
National Cancer Institute (NCI)Phase 2
CompletedT4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a
NCT00089180
National Cancer Institute (NCI)Phase 2